Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey.

¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave.

Journal

Neurologia
ISSN: 2173-5808
Titre abrégé: Neurologia (Engl Ed)
Pays: Spain
ID NLM: 101778590

Informations de publication

Date de publication:
May 2020
Historique:
received: 15 04 2020
accepted: 17 04 2020
pubmed: 5 5 2020
medline: 13 6 2020
entrez: 5 5 2020
Statut: ppublish

Résumé

The COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable. A key informant survey was used to enquire about the changes expected in the specialty over the next 5 years. The survey was completed by heads of neurology departments with broad knowledge of the situation, having been active during the pandemic. Despite a low level of consensus between participants, there was strong (85%) and moderate consensus (70%) about certain subjects, mainly the increase in precautions to be taken, the use of telemedicine and teleconsultations, the reduction of care provided in in-person consultations to avoid the presence of large numbers of people in waiting rooms, the development of remote training solutions, and the changes in monitoring visits during clinical trials. There was consensus that there would be no changes to the indication of complementary testing or neurological examination. The key informant survey identified the foreseeable changes in neurological care after the pandemic.

Identifiants

pubmed: 32364126
pii: S0213-4853(20)30071-2
doi: 10.1016/j.nrl.2020.04.006
pmc: PMC7165283
pii:
doi:

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

252-257

Informations de copyright

Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Références

Neurologia. 2020 May;35(4):245-251
pubmed: 32364119
Stroke. 2020 May;51(5):1356-1357
pubmed: 32228369
Neurologia. 2020 May;35(4):233-237
pubmed: 32336528
Rev Neurol. 1995 Jul-Aug;23(122):860-5
pubmed: 7497252
Neurology. 2020 May 26;94(21):905-906
pubmed: 32245844
Neurologia. 2020 Apr;35(3):170-175
pubmed: 32299636
Neurology. 2020 May 26;94(21):903-904
pubmed: 32238505
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Pain Symptom Manage. 2020 Jul;60(1):e12-e14
pubmed: 32240756
Neurology. 2020 May 12;94(19):809-810
pubmed: 32229625
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Syst Rev. 2017 Jul 3;6(1):128
pubmed: 28673333
Cureus. 2020 Mar 21;12(3):e7352
pubmed: 32328364
Ann Oncol. 2020 May;31(5):553-555
pubmed: 32201224
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Mov Disord. 2020 May;35(5):716-720
pubmed: 32291797
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
Neurol Sci. 2020 Apr;41(4):747-748
pubmed: 32180157
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Stroke. 2020 Jun;51(6):1891-1895
pubmed: 32233980
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810
pubmed: 32238336
Mov Disord. 2020 May;35(5):711-715
pubmed: 32250460
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814

Auteurs

J Matías-Guiu (J)

Servicio de Neurología, Hospital Clínico San Carlos, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.

J A Matias-Guiu (JA)

Servicio de Neurología, Hospital Clínico San Carlos, Madrid, España.

J Alvarez-Sabin (J)

Servicio de Neurología, Hospital Universitario de Vall d'Hebron, Barcelona, España.

J Ramon Ara (J)

Servicio de Neurología, Hospital Miguel Servet, Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, España.

J Arenillas (J)

Servicio de Neurología, Hospital Clínico de Valladolid, Valladolid, España.

I Casado-Naranjo (I)

Servicio de Neurología, Complejo Hospitalario Universitario de Cáceres, Cáceres, España.

M Castellanos (M)

Servicio de Neurología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, A Coruña, España.

M D Jimenez-Hernandez (MD)

Servicio de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, España.

J M Lainez-Andres (JM)

Servicio de Neurología, Hospital Clínico Universitario de Valencia, Valencia, España.

E Moral (E)

Hospital Moisès Broggi y Hospital General de l'Hospitalet, Barcelona, España.

A Morales (A)

Servicio de Neurología, Hospital Universitario Virgen de la Arrixaca, Murcia, España.

A Rodriguez-Antigüedad (A)

Servicio de Neurología, Hospital Universitario de Cruces, Bilbao, España.

T Segura (T)

Servicio de Neurología, Hospital General Universitario de Albacete, Albacete, España.

P Serrano-Castro (P)

Servicio de Neurología, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, España.

E Diez-Tejedor (E)

Servicio de Neurología, Hospital Universitario La Paz, Madrid, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH